Short-term Effects of Transdermal Estradiol on Female COVID-19 Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

9,169

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions

COVID-19Hormone Replacement Therapy

Interventions

DRUG

Climara 0.1Mg/24Hr Transdermal System

Transdermal estradiol patch is used.

OTHER

Hydrogel patch

Adhesive Hydrogel patch

Trial Locations (1)

Istanbul University-Cerrahpasa, Istanbul

All Listed Sponsors

collaborator

Turkish Menopause and Osteoporosis Society

UNKNOWN

collaborator

Karakoy Rotary Club

UNKNOWN

collaborator

Rebul Pharmacy

UNKNOWN

lead

Istanbul University - Cerrahpasa

OTHER

NCT05774405 - Short-term Effects of Transdermal Estradiol on Female COVID-19 Patients | Biotech Hunter | Biotech Hunter